A systematic review of neurocognitive dysfunction with overactive bladder medications
V Duong, A Iwamoto, J Pennycuff, B Kudish… - International …, 2021 - Springer
Introduction and hypothesis The aim of this study is to report cognitive dysfunction with
commonly used antimuscarinic overactive bladder medications in patients suffering from …
commonly used antimuscarinic overactive bladder medications in patients suffering from …
Oral pharmacotherapy for overactive bladder in older patients: mirabegron as a potential alternative to antimuscarinics
A Wagg, VW Nitti, C Kelleher… - … medical research and …, 2016 - Taylor & Francis
Objective Overactive bladder (OAB) is a particular challenge to treat in older adults with co-
morbid conditions taking multiple medications. Antimuscarinics (eg, solifenacin …
morbid conditions taking multiple medications. Antimuscarinics (eg, solifenacin …
[HTML][HTML] Risk of dementia associated with anticholinergic drugs for overactive bladder in adults aged≥ 55 years: nested case-control study
B Iyen, C Coupland, BG Bell, DM Ashcroft… - BMJ …, 2024 - pmc.ncbi.nlm.nih.gov
Objective To investigate whether different anticholinergic drug treatments for overactive
bladder have differential risks for incident dementia, in a large representative population of …
bladder have differential risks for incident dementia, in a large representative population of …
Choosing the most efficacious and safe oral treatment for idiopathic overactive bladder: a systematic review and network meta-analysis
H Mostafaei, H Salehi-Pourmehr, S Jilch… - European Urology …, 2022 - Elsevier
Context The choice of the most efficacious drug for patients with idiopathic overactive
bladder (IOAB) remains challenging. Objective The aim of this network meta-analysis was to …
bladder (IOAB) remains challenging. Objective The aim of this network meta-analysis was to …
Design and synthesis of novel 1, 3, 4‐oxadiazole based azaspirocycles catalyzed by NaI under mild condition and evaluated their antidiabetic and antibacterial …
AJ Radia, JN Lalpara, IJ Modasiya… - Journal of Heterocyclic …, 2021 - Wiley Online Library
A modest, efficient, and mild synthetic procedure has been developed for the synthesis of
novel series of 1, 3, 4‐oxadiazole containing azaspirocycles derivatives. The reaction of 1, 3 …
novel series of 1, 3, 4‐oxadiazole containing azaspirocycles derivatives. The reaction of 1, 3 …
Efficacy and safety of non-ablative vaginal erbium: YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with …
N Okui - World Journal of Urology, 2019 - Springer
Purpose To examine the efficacy and safety of non-ablative vaginal erbium: YAG laser (VEL)
for the treatment of overactive bladder syndrome (OAB) compared with those of two other …
for the treatment of overactive bladder syndrome (OAB) compared with those of two other …
Mirabegron for the treatment of overactive bladder: a review of efficacy, safety and tolerability with a focus on male, elderly and antimuscarinic poor-responder …
CR Chapple, E Siddiqui - Expert Review of Clinical Pharmacology, 2017 - Taylor & Francis
Introduction: Mirabegron is established as an alternative monotherapy to antimuscarinics for
the treatment of overactive bladder (OAB) symptoms. Initial studies focused on Western …
the treatment of overactive bladder (OAB) symptoms. Initial studies focused on Western …
Overactive bladder in the vulnerable elderly
GF Wolff, GA Kuchel, PP Smith - Research and reports in urology, 2014 - Taylor & Francis
Overactive bladder (OAB) is a common problem that may occur in individuals of all ages. It
has a considerable impact on patient quality of life, and although moderately effective …
has a considerable impact on patient quality of life, and although moderately effective …
Intravesical electromotive botulinum toxin type “A” administration for management of urinary incontinence secondary to neuropathic detrusor overactivity in children …
Objective To investigate the long-term efficacy and success rate of intravesical electromotive
botulinum toxin type A (BoNTA)“Dysport” administration in patients with myelomeningocele …
botulinum toxin type A (BoNTA)“Dysport” administration in patients with myelomeningocele …
Which antimuscarinic agents used in the treatment of overactive bladder increase heart rate? a prospective randomized clinical trial
Purpose To compare the heart rate increase side effect of different antimuscarinic drugs
used in overactive bladder (OAB). Methods Overall 341 patients were consecutively …
used in overactive bladder (OAB). Methods Overall 341 patients were consecutively …